Abstract
Figures and Tables
Fig. 1
Skin findings of patch test to antitubercular drugs read at 48 hours. Test drugs are isoniazid (INH), levofloxacin (LV), prothinamide (PTH), p-aminosalicylic acid (PAS), streptomycin (SM), ethambutol (ETM), cycloserine (CS), amoxicillin clavulanate (Am), pyrazinamide (Pyz), rifampicin (RFP) in clockwise direction from the right top.
![aard-3-297-g001](/upload/SynapseData/ArticleImage/0206aard/aard-3-297-g001.jpg)
Table 1
Summary of drug administration and related symptoms
![aard-3-297-i001](/upload/SynapseData/ArticleImage/0206aard/aard-3-297-i001.jpg)
● , administration of full dose; □ , discontinuation; ▲ , administration with desensitization protocol; △ , hypersensitivity reaction despite administration with desensitization protocol; PZA, pyrazinamide; SM, streptomycin; CS, cycloserine; PAS, p-aminosalicylic acid; PTH, prothionamide; LVFX, levofloxacin; KM, kanamycin; AC, amoxicillin clavulanate.
Table 2
Intravenous rapid desensitization protocol for kanamycin (target dose: 1,000 mg)
![aard-3-297-i002](/upload/SynapseData/ArticleImage/0206aard/aard-3-297-i002.jpg)
Table 3
Oral rapid desensitization protocol for prothionamide (target dose: 250 mg twice a day)
![aard-3-297-i003](/upload/SynapseData/ArticleImage/0206aard/aard-3-297-i003.jpg)
Table 4
Oral rapid desensitization protocol for cycloserine (target dose: 500 mg twice a day)
![aard-3-297-i004](/upload/SynapseData/ArticleImage/0206aard/aard-3-297-i004.jpg)
References
![crossref](/image/icon/bnr_ref_cross.gif)
![crossref](/image/icon/bnr_ref_cross.gif)
![crossref](/image/icon/bnr_ref_cross.gif)
![crossref](/image/icon/bnr_ref_cross.gif)
![crossref](/image/icon/bnr_ref_cross.gif)
![crossref](/image/icon/bnr_ref_cross.gif)
![crossref](/image/icon/bnr_ref_cross.gif)
![crossref](/image/icon/bnr_ref_cross.gif)